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Abstracts / Osteoarthritis and Cartilage 22 (2014) S7–S56S8controls. Furthermore, there was no signiﬁcant correlation between the
paired serum and synovial ﬂuid levels at baseline (Spearman R<0.2 for
all markers). The positive predictive value of a raised serum level of IL-6
or TSG-6 for an elevated synovial ﬂuid level respectively were 80% and
89%, but with negative predictive values of 49% and 20%. At 3 months
from baseline, analytes generally remained low in blood, and had also
normalised in synovial ﬂuid, where the latter was available. Exceptions
were MMP-3 and TSG-6, where elevated levels persisted in the serum
and synovial ﬂuid in a proportion of individuals at this later time.
Conclusions: Our ﬁndings validate the utility of the murine post-
traumatic OA model in identifying potential human joint injury
response biomarkers. In this translational setting, analysis of synovial
ﬂuid rather than blood appears essential for the accurate assay of cel-
lular products secreted into the joint in response to injury. Neither
serum nor plasma levels are clinically sensitive enough to be surrogates
for the intra-articular response. Investigation of the pathogenetic
relevance and prognostic value of an individual’s initial molecular
response to joint injury in prospective cohorts such as KICK is essential
to our understanding of post-traumatic OA.
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Purpose: Osteoarthritis (OA) is the most common joint disease. Among
the earliest lesions during OA development is disruption of the super-
ﬁcial zone (SZ) of articular cartilage. Our recent studies showed that the
chromatin protein high mobility group protein B2 (HMGB2) is uniquely
expressed in the SZ and its expression declines with aging in human
and mouse joints. Deletion of the hmgb2 gene leads to increased
severity of aging-related OA. HMGB2 supports SZ cell survival through
interactions with Wnt signaling and maintains the immature differ-
entiation status of these cells. To further elucidate HMGB2 functions we
performed gene expression analyses and identiﬁed EFEMP1 encoding
ﬁbulin-3 as a HMGB2 regulated gene. Fibulin-3 is one of sevenmembers
of the mammalian ﬁbulin family of glycoproteins. Fibulin-3 is expressed
in cartilage and bone structures in the embryo and ﬁbulin-3 peptides
are potential biomarkers for the diagnosis of OA. However, the
expression pattern and function of ﬁbulin-3 in adult joint tissues is not
well characterized. The purposes of this study were to examine ﬁbulin-
3 expression patterns in joint aging and OA and to investigate the role of
ﬁbulin-3 in OA pathogenesis.
Methods: Human knee joints were obtained at autopsy with approval
of the Human Subjects Committee. Joints were processed within 72
hours post-mortem. All animal experiments were performed according
to protocols approved by the Institutional Animal Care and Use Com-
mittee. Immunohistochemical analysis was performed on human and
mouse knee cartilage to determine changes in ﬁbulin-3 expression
during joint aging and in OA. To examine the role of ﬁbulin-3 in carti-
lage homeostasis, aging-related OA and experimental OA (induced by
transection of the medial meniscotibial ligament and the medial col-
lateral ligament) were investigated in wild type and ﬁbulin-3-/- mice.
To address whether ﬁbulin-3 is involved in regulating chondrocyte
differentiation and cell viability, human articular chondrocytes were
transfected with ﬁbulin-3-speciﬁc siRNA. Cells were harvested at 48
hours and 72 hours for quantitative PCR and Western blot analyses.
Following transfection with siRNA and incubation for 72 hours, cell
viability was determined using MTT assay. To further address the role of
ﬁbulin-3 during chondrogenesis, bonemarrowmesenchymal stem cells
(MSC) were transduced with lentivirus (LV) encoding EFEMP1 or con-
trol LV expressing LacZ, then MSC pellets were prepared and analyzed
for chondrogenesis. Statistically signiﬁcant differences between two
groups were determined by Mann-Whitney’s U test (non-parametric)
or Student’s t-test (parametric). Differences among 3 groups were
determined by Kruskal-Wallis (non-parametric one-way analysis of
variance) or Tukey-Kramer (parametric) procedures. P values of less
than 0.05 were considered statistically signiﬁcant.
Results: Fibulin-3 was speciﬁcally expressed in the SZ of normal car-
tilage in human and mouse knee joints. Fibulin-3 expression was
intracellular and in the extracellular matrix (ECM) and declined with
aging. Both aging-related OA and experimental OA were signiﬁcantly
more severe in ﬁbulin-3-/- mice comparedwith wild typemice. Fibulin-3-/- mice showed signiﬁcantly fewer SZ cells compared with WT mice
in 9 months. There was a signiﬁcant reduction in chondrocyte viability
following ﬁbulin-3 knockdown under low serum conditions. Fibulin-3
expression was high in MSC and decreased during chondrogenesis.
Suppression of ﬁbulin-3 by siRNA in MSC signiﬁcantly increased SOX9,
collagen II and aggrecan in articular chondrocytes, while the over-
expression of ﬁbulin-3 inhibited chondrogenesis in MSC.
Conclusions: We found that ﬁbulin-3 is speciﬁcally expressed in the SZ
of articular cartilage and its expression is reduced in aging. Fibulin-3
regulates survival and differentiation of adult progenitor cells in the SZ
of articular cartilage and its aging-related decline is an early event in OA
pathogenesis. Preventing or restoring aging-associated loss of ﬁbulin-3
in SZ chondrocytes has potential to delay or prevent onset of OA.
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Purpose: The purpose of this study is to investigate the role of Wnt16
following cartilage injury and osteoarthritis development. Our previous
studies showed that Wnt16 is up-regulated upon acute trauma -a
condition known to predispose to osteoarthritis (OA) - in an ex vivo
setting. Activation of Wnt signalling is associated with cartilage
breakdown and OA development, although the mechanisms and the
ligands responsible for it are still unclear. The aims of this study,
therefore, are i) to investigate whether Wnt16 contributes to the out-
come of experimental OA in vivo; ii) The molecular mechanism leading
to WNT16 up-regulation following injury and iii) identify which sig-
nalling pathway is activated by Wnt16 in vivo.
Methods: Articular chondrocytes were isolated from bovine metatarsal
joints. The cells were then stimulated with recombinant Wnt16 at dif-
ferent doses and gene expression analysis performed. OA was induced
by destabilization of the medial meniscus (DMM) in 8 week-old 129/Sv
mice Wnt16-/- or WT littermate. The animals were culled at 2, 7 days
and 8 weeks post surgery. The joints were either processed for gene
expression analysis, ﬁxed for bone analysis (mCt) or de-calciﬁed and
parafﬁn embedded, for histological, morphometric, and immunohis-
tochemical characterization. The degree of cartilage breakdown was
assessed by using OARSI score by two independent investigators. Six
animals/genotype were left ageing for 1 year to evaluate the develop-
ment of spontaneous OA. To test the involvement to oxidative stress in
Wnt16 modulation, organ cultures of articular cartilage explanted from
femoral heads were treated with H2O2 in presence/absence of a NADPH
oxidase inhibitor. Gene expression analysis for Wnt16 and cartilage
markers performed afterwards.
Results: Wnt16 expression was upregulated at 2 and 7 days post-DMM
and was associated with an increased expression of b-catenin. Modu-
lation of the Wnt-bcatenin pathway was conﬁrmed in vitro on bovine
articular chondrocytes stimulated with recombinant Wnt16. Wnt16-
deﬁcient mice developed more severe cartilage breakdown in com-
parison toWT littermate following DMM, whereas, if left unchallenged,
did not develop spontaneous OA with age. Wnt16-deﬁcient mice dis-
played a lower expression of lubricin, the absence of which is known to
result in OA. Finally, we found that mechanical trauma to cartilage
resulted in oxygen radical release, and this was required and sufﬁcient
to trigger WNT16 upregulation in chondrocytes. Indeed H2O2 alone
was sufﬁcient to up-regulate WNT16, whereas chemical blockade of
NAPDH oxidase inhibited WNT16 up-regulation induced by mechanical
trauma.
Conclusions: We demonstrated for the ﬁrst time that Wnt16 supports
cartilage homeostasis following injury, and it is required to reduce
degradation upon mechanical trauma. We also showed that oxidative
stress, previously thought to play a pathogenic role in cartilage break-
down in the ﬁrst phases of OA development, in our settings, drives
Wnt16 up-regulation, suggesting a new homeostatic role for oxidative
stress. Finally, we show that Wnt16 supports the expression of lubricin.
Our results shed new light on the role of Wnt signalling in the articular
